MGC Pharmaceuticals acquires MediCaNL to create an in-house research programme
MediCaNL Inc is an Israeli company providing specialist services worldwide to the pharmaceutical sector for the development of new medicines.
He explains, rather than pay for a third party consultant each time for their skills and resources, he wanted this resource to be in-house .
He goes on to add the cost effective attributes of this deal as MediCaNL offers clinical and preclinical trial services as well as assistance with clinical trials in the form of research data from past studies of all Phase I to IV using a variety of treatment methods.
MGC Pharmaceuticals acquires MediCaNL to create an in-house research programme
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.
MGC Pharmaceuticals acquires MediCaNL to create an in-house research programme
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
MGC Pharmaceuticals says next step is to convert our efforts in research into commercial revenue
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.